A case of Philadelphia chromosome-positive acute lymphocytic leukaemia with type I CD36 deficiency.
Marina MatsuiKoichi KajiwaraMasao TsukadaKanichi IwamaKazunari YamadaHideki KodoKatsuya SetoKaoru TonamiMoe AndoMika MatsuhashiNaoko Watanabe-OkochiNelson-Hirokazu TsunoYasuji KozaiPublished in: Vox sanguinis (2021)
If CD36-negative, allogeneic haematopoietic stem cell donors are unable to be found, the indications for HSCT in patients with type I CD36-deficiency should be carefully weighed. In the present case, molecular remission has been able to be maintained to the present day after completion of a two-year maintenance regimen.
Keyphrases
- stem cells
- acute lymphoblastic leukemia
- stem cell transplantation
- nk cells
- bone marrow
- liver failure
- replacement therapy
- low dose
- intensive care unit
- rheumatoid arthritis
- dna methylation
- gene expression
- drug induced
- acute respiratory distress syndrome
- smoking cessation
- extracorporeal membrane oxygenation
- cell therapy